Elequin Capital’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-303
| Closed | -$8.31K | – | 323 |
|
|
2024
Q4 | $8.31K | Buy |
303
+15
| +5% | +$412 | ﹤0.01% | 349 |
|
|
2024
Q3 | $7.33K | Sell |
288
-26
| -8% | -$662 | ﹤0.01% | 258 |
|
|
2024
Q2 | $7.95K | Sell |
314
-8
| -2% | -$203 | ﹤0.01% | 150 |
|
|
2024
Q1 | $9.96K | Buy |
+322
| New | +$9.96K | ﹤0.01% | 108 |
|
|
2023
Q3 | – | Sell |
-678
| Closed | -$11.7K | – | 415 |
|
|
2023
Q2 | $11.7K | Buy |
+678
| New | +$11.7K | 0.01% | 282 |
|
|
2022
Q4 | – | Sell |
-549
| Closed | -$5K | – | 630 |
|
|
2022
Q3 | $5K | Sell |
549
-426
| -44% | -$3.88K | ﹤0.01% | 320 |
|
|
2022
Q2 | $9K | Buy |
975
+92
| +10% | +$849 | ﹤0.01% | 244 |
|
|
2022
Q1 | $9K | Buy |
+883
| New | +$9K | ﹤0.01% | 168 |
|